Literature DB >> 31029508

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials.

Gennaro Daniele1, Laura Arenare2, Giovanni Scambia3, Carmela Pisano4, Roberto Sorio5, Enrico Breda6, Sabino De Placido7, Antonella Savarese8, Gabriella Ferrandina9, Francesco Raspagliesi10, Pierluigi Benedetti Panici11, Antonella Ferro12, Anita Rimanti13, Gennaro Cormio14, Domenica Lorusso15, Sabrina Chiara Cecere16, Simona Scalone17, Valentina Angela Marsico6, Cinzia Cardalesi18, Francesco Cognetti19, Vanda Salutari9, Laura Attademo20, Lorenzo Guizzaro21, Clorinda Schettino22, Maria Carmela Piccirillo23, Francesco Perrone24, Ciro Gallo25, Sandro Pignata26.   

Abstract

BACKGROUND: Chemotherapy-induced neutropenia (CIN) has been associated with improved prognosis in several cancer conditions. Contrasting data have been produced in ovarian cancer.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemotherapy-induced neutropenia; Cytotoxic dosing methods; Meta-analysis; Ovarian cancer; Prognostic factors; Retrospective-prospective design

Mesh：

Substances：

Year:  2019        PMID： 31029508     DOI： 10.1016/j.ygyno.2019.04.012

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


  2 in total

1.  Early onset neutropenia: a useful predictor of chemosensitivity and favorable prognosis in patients with serous ovarian cancer.

Authors:  Yijing He; Ting Li; Jue Liu; Qiong Ou; Junlin Zhou
Journal:  BMC Cancer       Date:  2020-02-12       Impact factor: 4.430

Review 2.  Current management of chemotherapy-induced neutropenia in adults: key points and new challenges: Committee of Neoplastic Supportive-Care (CONS), China Anti-Cancer Association Committee of Clinical Chemotherapy, China Anti-Cancer Association.

Authors:  Yi Ba; Yuankai Shi; Wenqi Jiang; Jifeng Feng; Ying Cheng; Li Xiao; Qingyuan Zhang; Wensheng Qiu; Binghe Xu; Ruihua Xu; Bo Shen; Zhiguo Luo; Xiaodong Xie; Jianhua Chang; Mengzhao Wang; Yufu Li; Yuerong Shuang; Zuoxing Niu; Bo Liu; Jun Zhang; Li Zhang; Herui Yao; Conghua Xie; Huiqiang Huang; Wangjun Liao; Gongyan Chen; Xiaotian Zhang; Hanxiang An; Yanhong Deng; Ping Gong; Jianping Xiong; Qinghua Yao; Xin An; Cheng Chen; Yanxia Shi; Jialei Wang; Xiaohua Wang; Zhiqiang Wang; Puyuan Xing; Sheng Yang; Chenfei Zhou
Journal:  Cancer Biol Med       Date:  2020-12-15       Impact factor: 4.248
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.